Tinzaparin Provides Lower Lipid Profiles in Maintenance Hemodialysis Patients: A Cross-Sectional Observational Study

Figure 2

Subgroup analysis of the effect of tinzaparin on (a) serum triglyceride levels and (b) serum total cholesterol level in hemodialysis patients. The model for serum triglyceride levels was adjusted for sex, body mass index, systolic blood pressure, hemodialysis time, total iron-binding capacity, sodium, phosphate, and uric acid. The model for serum total cholesterol levels was adjusted for sex, diabetes mellitus, albumin, hemoglobin, hemodialysis time, and total iron-binding capacity.

(a)

(b)